These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 231197)
1. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms. Hait WN; Weiss B Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197 [No Abstract] [Full Text] [Related]
2. Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells. Epstein PM; Mills JS; Ross CP; Strada SJ; Hersh EM; Thompson WJ Cancer Res; 1977 Nov; 37(11):4016-23. PubMed ID: 198126 [No Abstract] [Full Text] [Related]
3. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts. Epstein PM; Hachisu R Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():303-24. PubMed ID: 6202124 [No Abstract] [Full Text] [Related]
4. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells]. Azhaeva EV; Severin ES Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690 [TBL] [Abstract][Full Text] [Related]
5. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system. Strada SJ; Martin MW; Thompson WJ Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518 [No Abstract] [Full Text] [Related]
6. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes. Sobolev AS; Rybalkin SD Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings]. Ilien B; Landry Y Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846 [No Abstract] [Full Text] [Related]
9. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues]. Medvedeva MV Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612 [TBL] [Abstract][Full Text] [Related]
10. Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells. Manganiello VC; Yamamoto T; Elks M; Lin MC; Vaughan M Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():291-301. PubMed ID: 6326529 [No Abstract] [Full Text] [Related]
11. [Changes in the ratio of cyclic nucleotide phosphodiesterase forms in the thymocytes of irradiated mice]. Rybalkin SD; Sobolev AS Radiobiologiia; 1986; 26(2):167-70. PubMed ID: 3010370 [TBL] [Abstract][Full Text] [Related]
12. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes]. Rybalkin SD; Kurennaia GS; Sobolev AS Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat. Levin RM; Weiss B Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349 [No Abstract] [Full Text] [Related]
14. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Marcoz P; Prigent AF; Lagarde M; Nemoz G Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications. Hidaka H; Endo T Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253 [No Abstract] [Full Text] [Related]
16. Regulation of multiple forms of cyclic nucleotide phosphodiesterase from bovine hypothalamus: new factors modulating enzyme activity. Galoyan AA; Gurvitz BYa Neurochem Res; 1985 Nov; 10(11):1467-81. PubMed ID: 3003614 [TBL] [Abstract][Full Text] [Related]
17. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3? Kass DA Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937 [No Abstract] [Full Text] [Related]
18. Proteolytic activation of Ca2+-dependent cyclic nucleotide phosphodiesterase from Escherichia coli. Iwasa Y Horm Metab Res; 1981 Jul; 13(7):414-5. PubMed ID: 6268507 [TBL] [Abstract][Full Text] [Related]
19. Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine. Thompson WJ; Ross CP; Hersh EM; Epstein PM; Strada SJ J Cyclic Nucleotide Res; 1980; 6(1):25-36. PubMed ID: 6155390 [TBL] [Abstract][Full Text] [Related]
20. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates. Grewal J; Karuppiah N; Mutus B Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]